Asia / TAIWAN
To continue to view the full report
Buy this company's report, or subscribe to a plan.
Company Overview
Lumosa Therapeutics Co., Ltd. is a drug development company. It engages in the business of developing drugs for the central nervous system, oncology, and inflammatory diseases. The firm operates through the following geographical segments: Taiwan, Asia, America, and Europe. The company was founded on November 13, 2000 and is headquartered in Taipei, Taiwan.
Lumosa Therapeutics Co., Ltd. is a drug development company. It engages in the business of developing drugs for the central nervous system, oncology, and inflammatory diseases. The firm operates through the following geographical segments: Taiwan, Asia, America, and Europe. The company was founded on November 13, 2000 and is headquartered in Taipei, Taiwan.
Includes quarterly earnings and dividends.
Company Details
| Major Industry | Pharmaceuticals & Biotechnology |
| Sub Industry | Pharmaceutical Preparations |
| Country | TAIWAN |
| Employees | 39 |
| Reporting Unit | Billions |
| Primary Exchange | Unknown exchange |
| Instrument Type | Equity |
| Website | http://www.lumosa.com.tw |
| Wright ID | C158DCHL8 |
Key Metrics
| Current price | $68.50 |
| Market cap | $11.38 B |
| P/E ratio | n/a |
| 52-week perf. | -67.4% |
| Common shares | 166.1 M |
| Closely held | 59.3 M |
| Share type | Gu |
| Quality rating | CBL0 |
| Dividend yield | 0.00% |
Recent stock performance
| 1 Week | +0.1% |
| 4 Week | -19.4% |
| 13 Week | -21.3% |
Officers
| Chairman & General Manager | Jung-Chin Lin |
| Chief Operating Officer | Peijun Chen |
Address
No3-2 Park Street Nangang District
TAIPEI
TAIWAN
115
| Phone | n/a |
Quarterly Earnings & Dividends
Quarterly earnings and dividend history is not available for this company.
Try another report for annual statements, Wright Quality history or comparative analysis.